Iran may recalibrate mRNA vaccine against new COVID strains

TEHRAN – Iran's resolute commitment to combating the COVID-19 pandemic takes a momentous stride as the nation's pioneering mRNA coronavirus vaccine successfully completes its Phase 1 clinical trial, showcasing the potential to be recalibrated in response to evolving virus strains.